GlassScriptPhysician profile
Ramandeep Brar
NPI 1821165549
$78,819.93
in general payments reported to CMS, 2019-2025
39 companies · $883 in 2025
The $883 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,508 · 2020: $5,267 · 2021: $17K · 2022: $13K · 2023: $17K · 2024: $22K · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Travel and Lodging: $6,774 · Food and Beverage: $5,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,065.00 |
| Travel and Lodging | $6,774.41 |
| Food and Beverage | $5,166.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $60,739.02 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $8,710.00 | 2020-2024 | Jardiance |
| Medtronic, INC. | $3,090.69 | 2022-2023 | Micra, Venaseal |
| Novartis Pharmaceuticals Corporation | $1,237.91 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $844.57 | 2019-2024 | Xarelto |
| Pfizer INC. | $522.48 | 2019-2025 | |
| Medical Device Business Services, INC. | $473.38 | 2019 | |
| Boston Scientific Corporation | $324.59 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Covidien LP | $254.32 | 2019 | |
| Merck Sharp & Dohme LLC | $233.06 | 2021-2025 | Verquvo, Steglatro, Belsomra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $229.22 | 2019-2023 | Lifevest |
| Biotronik INC. | $221.11 | 2019-2025 | Amvia Edge |
| Amgen INC. | $213.16 | 2019-2025 | Repatha, Repatha |
| Atricure, INC. | $161.62 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $155.32 | 2019-2024 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $132.77 | 2021-2025 | Amplatzer |
| Abiomed | $129.05 | 2025 | |
| Cvrx, INC. | $129.01 | 2023-2024 | Barostim Neo System |
| Irhythm Technologies, INC. | $108.63 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Impulse Dynamics (USA) INC. | $106.14 | 2023 | Optimizer |
| Novo Nordisk INC | $98.13 | 2025 | Wegovy, Ozempic |
| Bardy Diagnostics, INC. | $87.79 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $86.46 | 2020-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $68.03 | 2022-2023 | Eliquis |
| Biosense Webster, INC. | $55.13 | 2022-2023 | Carto 3 |
| Bayer Healthcare Pharmaceuticals INC. | $53.29 | 2021-2025 | |
| Scpharmaceuticals INC. | $51.32 | 2024-2025 | |
| Amarin Pharma, INC. | $45.29 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $37.12 | 2020-2021 | |
| Resmed Corp | $30.02 | 2022 | |
| Csl Behring | $24.79 | 2020 | |
| Altathera Pharmaceuticals LLC | $24.25 | 2025 | Sotalol Hydrochloride |
| Akcea Therapeutics, INC. | $23.84 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $20.80 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $20.44 | 2023 | Assure Wcd |
| Inspire Medical Systems, INC. | $20.38 | 2025 | Inspire |
| Medtronic Vascular, INC. | $19.72 | 2019 | |
| Baxter Healthcare | $19.18 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Tactile Systems Technology INC | $17.90 | 2024 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramandeep Brar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.